NextBioMedical Signs Distribution Agreement with Terumo Europe for Nexpier-F
NextBioMedical has signed a distribution agreement with Terumo Europe for 'Nexpier-F' in selected countries within the Europe, Middle East, and Africa (EMEA) region.
According to NextBioMedical on June 1, under this agreement, Terumo will be exclusively responsible for the sales and distribution of Nexpier-F in certain countries of the EMEA region. Both companies plan to gradually expand the scope of their partnership to additional territories, based on market performance and the success of their collaboration.
Terumo, a global medical device company founded in Tokyo, Japan in 1921, operates in over 160 countries and regions worldwide. The company provides a wide range of medical solutions focused on therapeutic procedures, hospital operations, and life sciences, and is recognized as a leader in the global medical device industry.
Nexpier-F, developed by NextBioMedical, is an intravascular embolization device used for vascular embolization. It has obtained certifications from Korea KMFDS, Europe CE-MDD, and Canada, and is currently being used in actual clinical settings. The company is also smoothly conducting clinical trials for U.S. FDA approval and is continuously participating in major global conferences to expand product awareness and its professional network.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
A NextBioMedical representative stated, "We have steadily accumulated meaningful clinical data based on CE certification," adding, "Collaboration with a global medical device company like Terumo is a very significant step forward in our market expansion strategy."
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.